506 related articles for article (PubMed ID: 10622254)
1. p53 inhibition by the LANA protein of KSHV protects against cell death.
Friborg J; Kong W; Hottiger MO; Nabel GJ
Nature; 1999 Dec 23-30; 402(6764):889-94. PubMed ID: 10622254
[TBL] [Abstract][Full Text] [Related]
2. Identification of the gene encoding the major latency-associated nuclear antigen of the Kaposi's sarcoma-associated herpesvirus.
Kedes DH; Lagunoff M; Renne R; Ganem D
J Clin Invest; 1997 Nov; 100(10):2606-10. PubMed ID: 9366576
[TBL] [Abstract][Full Text] [Related]
3. Distinct patterns of viral antigen expression in Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus coinfected body-cavity-based lymphoma cell lines: potential switches in latent gene expression due to coinfection.
Callahan J; Pai S; Cotter M; Robertson ES
Virology; 1999 Sep; 262(1):18-30. PubMed ID: 10489337
[TBL] [Abstract][Full Text] [Related]
4. Seroreactivity to Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) latent nuclear antigen in AIDS-associated Kaposi's sarcoma patients depends on CD4+ T-cell count.
de Souza VA; Pierrotti LC; Sumita LM; Freire WS; Segurado AA; Pannuti CS
J Med Virol; 2007 Oct; 79(10):1562-8. PubMed ID: 17705173
[TBL] [Abstract][Full Text] [Related]
5. Comparison of human sera reactivities in immunoblots with recombinant human herpesvirus (HHV)-8 proteins associated with the latent (ORF73) and lytic (ORFs 65, K8.1A, and K8.1B) replicative cycles and in immunofluorescence assays with HHV-8-infected BCBL-1 cells.
Zhu L; Wang R; Sweat A; Goldstein E; Horvat R; Chandran B
Virology; 1999 Apr; 256(2):381-92. PubMed ID: 10191203
[TBL] [Abstract][Full Text] [Related]
6. Transcription profile of Kaposi's sarcoma-associated herpesvirus in primary Kaposi's sarcoma lesions as determined by real-time PCR arrays.
Dittmer DP
Cancer Res; 2003 May; 63(9):2010-5. PubMed ID: 12727810
[TBL] [Abstract][Full Text] [Related]
7. Accumulation of heterochromatin components on the terminal repeat sequence of Kaposi's sarcoma-associated herpesvirus mediated by the latency-associated nuclear antigen.
Sakakibara S; Ueda K; Nishimura K; Do E; Ohsaki E; Okuno T; Yamanishi K
J Virol; 2004 Jul; 78(14):7299-310. PubMed ID: 15220403
[TBL] [Abstract][Full Text] [Related]
8. Intracellular-activated Notch1 can reactivate Kaposi's sarcoma-associated herpesvirus from latency.
Lan K; Murakami M; Choudhuri T; Kuppers DA; Robertson ES
Virology; 2006 Aug; 351(2):393-403. PubMed ID: 16701788
[TBL] [Abstract][Full Text] [Related]
9. Physical and functional interactions between STAT3 and Kaposi's sarcoma-associated herpesvirus-encoded LANA.
Muromoto R; Okabe K; Fujimuro M; Sugiyama K; Yokosawa H; Seya T; Matsuda T
FEBS Lett; 2006 Jan; 580(1):93-8. PubMed ID: 16364321
[TBL] [Abstract][Full Text] [Related]
10. The latency-associated nuclear antigen tethers the Kaposi's sarcoma-associated herpesvirus genome to host chromosomes in body cavity-based lymphoma cells.
Cotter MA; Robertson ES
Virology; 1999 Nov; 264(2):254-64. PubMed ID: 10562490
[TBL] [Abstract][Full Text] [Related]
11. Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen induces chromosomal instability through inhibition of p53 function.
Si H; Robertson ES
J Virol; 2006 Jan; 80(2):697-709. PubMed ID: 16378973
[TBL] [Abstract][Full Text] [Related]
12. Lytic but not latent infection by Kaposi's sarcoma-associated herpesvirus requires host CSL protein, the mediator of Notch signaling.
Liang Y; Ganem D
Proc Natl Acad Sci U S A; 2003 Jul; 100(14):8490-5. PubMed ID: 12832621
[TBL] [Abstract][Full Text] [Related]
13. Activated Nrf2 Interacts with Kaposi's Sarcoma-Associated Herpesvirus Latency Protein LANA-1 and Host Protein KAP1 To Mediate Global Lytic Gene Repression.
Gjyshi O; Roy A; Dutta S; Veettil MV; Dutta D; Chandran B
J Virol; 2015 Aug; 89(15):7874-92. PubMed ID: 25995248
[TBL] [Abstract][Full Text] [Related]
14. Distinct expression of Kaposi's sarcoma-associated herpesvirus-encoded proteins in Kaposi's sarcoma and multicentric Castleman's disease.
Abe Y; Matsubara D; Gatanaga H; Oka S; Kimura S; Sasao Y; Saitoh K; Fujii T; Sato Y; Sata T; Katano H
Pathol Int; 2006 Oct; 56(10):617-24. PubMed ID: 16984619
[TBL] [Abstract][Full Text] [Related]
15. Transformation of primary human endothelial cells by Kaposi's sarcoma-associated herpesvirus.
Flore O; Rafii S; Ely S; O'Leary JJ; Hyjek EM; Cesarman E
Nature; 1998 Aug; 394(6693):588-92. PubMed ID: 9707121
[TBL] [Abstract][Full Text] [Related]
16. Differential regulation of the overlapping Kaposi's sarcoma-associated herpesvirus vGCR (orf74) and LANA (orf73) promoters.
Jeong J; Papin J; Dittmer D
J Virol; 2001 Feb; 75(4):1798-807. PubMed ID: 11160678
[TBL] [Abstract][Full Text] [Related]
17. Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 infection in reactive lymphoid tissues: a model for KSHV/HHV-8-related lymphomas?
Lazzi S; Bellan C; Amato T; Palummo N; Cardone C; D'Amuri A; De Luca F; Beyanga M; Facchetti F; Tosi P; Leoncini L
Hum Pathol; 2006 Jan; 37(1):23-31. PubMed ID: 16360412
[TBL] [Abstract][Full Text] [Related]
18. Kaposi's sarcoma-associated herpesvirus (KSHV)/human herpesvirus 8 (HHV-8) as a tumour virus.
Cathomas G
Herpes; 2003 Dec; 10(3):72-7. PubMed ID: 14759339
[TBL] [Abstract][Full Text] [Related]
19. Kaposi's sarcoma-associated herpesvirus LANA2 is a B-cell-specific latent viral protein that inhibits p53.
Rivas C; Thlick AE; Parravicini C; Moore PS; Chang Y
J Virol; 2001 Jan; 75(1):429-38. PubMed ID: 11119611
[TBL] [Abstract][Full Text] [Related]
20. Identification of B cell epitopes at the C-terminus of latency-associated nuclear protein of the kaposi's sarcoma-associated herpesvirus.
Yao S; Tang Q; Cheng L; Zeng Y; Chen X; Qin D; Lv Z; Lu C
Acta Virol; 2007; 51(2):109-18. PubMed ID: 17900217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
